VANCOUVER, June 22 /CNW/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or
the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international
pharmaceutical company, today announced the results of the Annual Shareholders
Meeting held on June 21, 2009 in Hong Kong, China.
There were 50,209,377 shares equaling 74.87% of the outstanding shares
represented at this meeting. The shareholders re-elected the following eight
persons to serve as members of the Board of Directors for the Company: Mr.
Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr.
Yiu Kwong Sun, M.D., Mr. Peter Mak, Dr. Heinz Frey and Dr. Jin Li.
For further information:
For further information: Dragon Pharmaceutical Inc., Maggie Deng, COO,
Telephone: (604) 669-8817, or North America Toll Free: 1-877-388-3784, Email:
email@example.com, Website: www.dragonpharma.com